Today’s Discoveries, Tomorrow’s Innovations
Each year, more than 62,000 Americans are diagnosed with pancreatic cancer. The clinical team at Jefferson is internationally renowned, and ranked among the best for both Cancer Care and Gastroenterology/GI Surgery by U.S. News & World Report. Our research team is equally excellent, investigating innovative techniques for detection, prevention, and treatment of pancreatic cancer and related diseases.
Your gift to Jefferson’s pancreatic cancer research will provide support specifically for identifying biomarkers and molecular targets for early detection and tumor recurrence, understanding the role of energy production in cancer resistance to therapy, uncovering unique vulnerabilities of cancer cells to develop novel therapies, and more.